ArticleBMC neurology2024

Study protocol of the GRoningen early-PD Ambroxol treatment (GREAT) trial: a randomized, double-blind, placebo-controlled, single center trial with ambroxol in Parkinson patients with a GBA mutation.

O Siemeling et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.